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a b s t r a c t
The presence of allicin in green garlic plant extracts was investigated. Allicin in aqueous extracts from
green garlic leaf, shoot and young bulbs were determined by HPLC. Allicin was present at highest level
in extracts from whole green garlic plant at 0.48 ± 0.01 mg/mL, followed by that in shoot and leaf extracts
at 0.44 ± 0.00 and 0.26 ± 0.01 mg/mL, respectively. The results obtained in this study offer green garlic as
a new source of allicin, as green garlic plant is used as a favourite vegetable in many countries.
Ó 2009 Elsevier Ltd. All rights reserved.
1. Introduction
Garlic (Allium sativum) has been a subject of considerable inter-
est as a medicine world-wide since ancient times. Several lines of
evidence through both in vitro and in vivo studies have revealed
pharmacological potentials of garlic. In vitro studies demonstrated
its antimicrobial (Ankri & Mirelman, 1999), antithrombotic, anti-
cancer, anti-platelet aggregation and antioxidant (Corzo-Martínez,
Corzo, & Villamiel, 2007) activities. In vivo studies, both in animal
models and human clinical trials, have demonstrated beneficial ef-
fects of garlic in a large number of pathological conditions, includ-
ing hyperlipidemia (Jabbari, Argani, Ghorbanihaghjo, & Mahdavi,
2005), cardiovascular disorders and arteriosclerosis (Rahman &
Lowe, 2006). Cancer preventative properties of garlic have also
been reported (Ejaz, Woong, & Ejaz, 2003). Epidemiologic studies
have revealed the lower risk of stomach cancer in people with high
garlic intake (Galeone et al., 2006).
Main pharmacological effects of garlic are attributed to its
organosulphur compounds (Tapiero, Townsend, & Tew, 2004). Alli-
cin is the chief biologically active component of garlic (Stoll & See-
beck, 1951). Allicin is not present in the intact plant, but is formed
upon crushing of garlic bulbs due an enzymatic reaction between
non-protein amino acid ‘‘alliin, a precursor molecule” and the en-
zyme alliinase. These molecules are originally present in intact gar-
lic but kept in distinct compartments (Lanzotti, 2006). Allicin’s
biological effects were suggested to be due to its thiol-disulphide
exchange reactions with the sulphydryl enzymes (Rabinkov et al.,
1998) which has been confirmed by its blocking effect on the
mammalian, parasitic and plant enzymes in vitro (Ankri et al.,
1997; Juszkiewicz et al., 2004; Wills, 1956).
Although, there is controversy on stability of allicin in biological
fluids (Freeman & Kodera, 1995), recently in a double-blinded, pla-
cebo-controlled study has shown allicin as a potential agent for
reducing exercise-induced muscle damage in athletes (Su, Tian,
Zhang, & Zhang, 2008). Additionally, it has been demonstrated that
most of the other biologically active components present in garlic
extract are derived from allicin (Brodnitz, Pascale, & Derslice,
1971). Thus, the beneficial effects of garlic is due to allicin content
in garlic preparations.
All studies conducted on garlic, used root bulbs of the garlic
plant. Garlic bulbs contain alliin and alliinase at about 1.7% and
2.8% of their dry weight, respectively (Lawson, 1996). Crushing of
garlic bulbs produces high but variable amounts of allicin, ranging
from 1.61% to 13.03% of their dry weight (Baghalian, Ziai, Naghavi,
Naghdi Badi, & Khalighi, 2005). Few studies have evaluated the
compositions and therapeutic values of other parts of garlic plant.
Because of the paucity of research in this topic we conducted to
evaluate the content of allicin in green garlic plant.
2. Materials and methods
2.1. Materials
Reagent grade standard allicin with a purity of 99.39% was
purchased from LKT laboratories Inc. (St Paul, MN, USA) and stored
at ÿ70 °C until use. HPLC grade methanol and ethylparaben (99%
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